Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Factors contributing to retroviral integration have been intractable because past studies have not precisely located genomic sites of proviruses in sufficient numbers for significant analysis. In this study, 903 murine leukemia virus (MLV) and 379 human immunodeficiency virus–1 (HIV-1) integrations in the human genome were mapped. The data showed that MLV preferred integration near the start of transcriptional units (either upstream or downstream) whereas HIV-1 preferred integration anywhere in the transcriptional unit but not upstream of the transcriptional start. Defining different integration site preferences for retroviruses will have important ramifications for gene therapy and may aid in our understanding of the factors directing the integration process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The well-understood integration preferences of HIV-1 for active transcription units72 and MLV for promoter/enhancer regions73–75 are in large part dictated via specific interactions of the respective IN proteins with chromatin-bound host factors.”
From Structure and function of retroviral integrase (2022) · cites this paper as [73]
In the citing paper
“Multiple studies now indicate that gammaretroviral vectors such as the vectors used in the two SCID-X1 trials preferentially integrate into the 5′ end of genes, near the transcription start sites[47].”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [47]
In the citing paper
“Finally, the preferred sequences of the genome for integration are different from the γ-RVV, with LVV preferentially integrating in genes and introns away for transcriptional start sites preferred by γ-RVV.20”
From Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy (2025) · cites this paper as [20]
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
CpG islands as gene markers in the human genome
Larsen, F., Gundersen, G., Lopez, R., & Prydz, H. (1992) · Genomics · doi:10.1016/0888-7543(92)90024-m · Cited by 922
Pryciak, P. M., & Varmus, H. E. (1992) · Cell · doi:10.1016/0092-8674(92)90289-o · Cited by 273
Introducing RefSeq and LocusLink: curated human genome resources at the NCBI
Pruitt, K. D., Katz, K. S., Sicotte, H., & Maglott, D. R. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01882-x · Cited by 241
Check, E. (2002) · Nature · doi:10.1038/420116a · Cited by 238
Pruss, D., Bushman, F. D., & Wolffe, A. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5913 · Cited by 236
Transcriptionally active genome regions are preferred targets for retrovirus integration
Scherdin, U., Rhodes, K., & Breindl, M. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.907-912.1990 · Cited by 210
Research works printed but not linked: 2
- National Center for Biotechnology Information Reference Sequence Project (RefSeq) www.ncbi.nlm.nih.gov/RefSeq/.
- The database is available online at www.ncbi.nlm.nih.gov/geo/.
Cited by
Items 101–200 of 1,000
Tréand, C., du Chéné, I., Brès, V., Kiernan, R., Benarous, R., Benkirane, M., & Emiliani, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601074 · Cited by 179
“On the contrary, HIV-1 preferentially integrates within coding sequences of transcriptionally active genes (Schroder et al, 2002; Wu et al, 2003).”
BackgroundModlich, U. (2005) · Blood · doi:10.1182/blood-2004-11-4535 · Cited by 190
A CRISPR toolbox to study virus–host interactions
Puschnik, A. S., Majzoub, K., Ooi, Y. S., & Carette, J. E. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.29 · Cited by 191
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
Puthenveetil, G., Scholes, J., Carbonell, D., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A. L., Yee, J.-K., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1427 · Cited by 182
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stoiber, S., Cadilha, B. L., Benmebarek, M.-R., Lesch, S., Endres, S., & Kobold, S. (2019) · Cells · doi:10.3390/cells8050472 · Cited by 180
“Both γ-retroviruses and lentiviruses integrate semi-randomly within the host cell genome, thereby harboring the risk for insertional mutagenesis and dysregulation of genes adjacent to the integration site [117,118].”
BackgroundWan, Y., Anastasakis, D. G., Rodriguez, J., Palangat, M., Gudla, P., Zaki, G., Tandon, M., Pegoraro, G., Chow, C. C., Hafner, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.012 · Cited by 187
Xia, X., Zhang, Y., Zieth, C. R., & Zhang, S.-C. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0057 · Cited by 166
“Studies have shown that lentiviral vectors do not integrate into the host genome randomly, but instead favor gene expression hotspots (32,33).”
Derse, D., Crise, B., Li, Y., Princler, G., Lum, N., Stewart, C., McGrath, C. F., Hughes, S. H., Munroe, D. J., & Wu, X. (2007) · Journal of Virology · doi:10.1128/jvi.02752-06 · Cited by 173
“(57) AY516881–AY517469 CD34 cell Trobridge et al.”
BackgroundMethodInfluentialSelf-citationInhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA
Godfrey, A., Anderson, J., Papanastasiou, A., Takeuchi, Y., & Boshoff, C. (2005) · Blood · doi:10.1182/blood-2004-08-3052 · Cited by 180
Zhang, F., Thornhill, S. I., Howe, S. J., Ulaganathan, M., Schambach, A., Sinclair, J., Kinnon, C., Gaspar, H. B., Antoniou, M., & Thrasher, A. J. (2007) · Blood · doi:10.1182/blood-2006-12-060814 · Cited by 176
Nucleocapsid protein function in early infection processes
Thomas, J. A., & Gorelick, R. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.006 · Cited by 164
“…into chromosomal DNA by different retroviruses, it has been determined that MLV tends to integrate into promoter regions (Mitchell et al., 2004; Wu et al., 2003), HIV-1 and SIV tend to integrate into actively transcribed genes (Barr et al., 2006; Bushman, 2002; Crise et al., 2005; Mitchell et…”
BackgroundViral Vectors: The Road to Reducing Genotoxicity
David, R. M., & Doherty, A. T. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw220 · Cited by 170
“…(TSS), gene regulatory elements (e.g. promoters/enhancers) (Cattoglio et al., 2010; De Ravin et al., 2014; LaFave et al., 2014; Mitchell et al., 2004; Niederer and Bangham, 2014; Wu et al., 2003), DNase-I hypersensitive sites (HSS) (Lewinski et al., 2006) and CpG islands (Suerth et al., 2014).”
BackgroundInfluentialDe Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F. D., Landuyt, B., Husson, S. J., Busschots, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.040 · Cited by 175
“When integration sites were binned based on their distance to TSSs and CpG or DHS island midpoints (Figure 4B,C,D, respectively), LEDGF1-324mBRD4ETSEED overexpression targeted integration away from the TSS, CpG island and DHS midpoints (compare red and green bars), a pattern reminiscent of that of lentiviral vector in…”
BackgroundInfluentialLarge-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells
Miller, D. G., Trobridge, G. D., Petek, L. M., Jacobs, M. A., Kaul, R., & Russell, D. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11434-11442.2005 · Cited by 171
“In contrast, the PCR methods used to sequence murine leukemia virus and human immunodeficiency virus integration junctions (40, 46) generated sequences with average match lengths of 98 and 191 bp, respectively, when aligned by our criteria.”
BackgroundMethodResultInfluentialLentiviral vectors: are they the future of animal transgenesis?
Park, F. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2007 · Cited by 170
“This was subsequently validated by other groups (72, 82, 136, 140).”
BackgroundMethodCherepanov, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl885 · Cited by 173
“The lentiviruses whose integration site preferences have been reported to-date [HIV-1, HIV-2, simian immunodeficiency virus (SIV), equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV)] share a strong bias toward integration within transcription units (8–13), whereas a gammaretrovirus MLV favor…”
De Palma, M., Montini, E., de Sio, F. R. S., Benedicenti, F., Gentile, A., Medico, E., & Naldini, L. (2005) · Blood · doi:10.1182/blood-2004-03-0798 · Cited by 175
“Thus, our results confirm and extend the conclusions of the study by Wu et al.(7).”
ResultGeneration of Transgenic Cattle by Lentiviral Gene Transfer into Oocytes1
Hofmann, A., Zakhartchenko, V., Weppert, M., Sebald, H., Wenigerkind, H., Brem, G., Wolf, E., & Pfeifer, A. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.028472 · Cited by 170
“Recently, two patients treated with MLV-based vectors developed leukemia because of insertions of the MLV provirus in close proximity of a proto-oncogene promoter (LMO2) [22].”
BackgroundInfluentialViral vectors for gene therapy: Current state and clinical perspectives
Lukashev, A. N., & Zamyatnin, A. A. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070063 · Cited by 156
Vargas, J. E., Chicaybam, L., Stein, R. T., Tanuri, A., Delgado-Cañedo, A., & Bonamino, M. H. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1047-x · Cited by 154
“Given the safer integration profile [153] when compared to retrovirus [154], lentivirus [155] and PB [116], SB is currently being tested in ten clinical trials of T cell immunotherapy (Additional file 2: Table S2).”
MethodNuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 201
The Past, Present, and Future of Non-Viral CAR T Cells
Moretti, A., Ponzo, M., Nicolette, C. A., Tcherepanova, I. Y., Biondi, A., & Magnani, C. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867013 · Cited by 180
Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase
Llano, M., Delgado, S., Vanegas, M., & Poeschla, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408508200 · Cited by 157
Mining Microarray Data at NCBI\'s Gene Expression Omnibus (GEO)<fntref rid=\"ch14fnt1\">*</fntref>
Barrett, T., & Edgar, R. (2006) · Gene Mapping, Discovery, and Expression · doi:10.1385/1-59745-097-9:175 · Cited by 160
“Researchers can look to see what the preponderance of evidence indicates about the behavior of a gene, or group of genes (7,8).”
BackgroundGogol-Döring, A., Ammar, I., Gupta, S., Bunse, M., Miskey, C., Chen, W., Uckert, W., Schulz, T. F., Izsvák, Z., & Ivics, Z. (2016) · Molecular Therapy · doi:10.1038/mt.2016.11 · Cited by 160
Holman, A. G., & Coffin, J. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501646102 · Cited by 164
Shah, N. N., Qin, H., Yates, B., Su, L., Shalabi, H., Raffeld, M., Ahlman, M. A., Stetler-Stevenson, M., Yuan, C., Guo, S., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000219 · Cited by 165
“However, lentiviral vectors do preferentially integrate into actively transcribed genes, which still poses potential risk of mutagenesis.(14,17) This concern is enhanced by the demonstration that insertion of an HIV provirus within specific regions of the MKL2 and BACH2 genes in HIVinfected patients can cause a clonal…”
BackgroundSelf-citationHuman cell proteins and human immunodeficiency virus DNA integration
Turlure, F. (2004) · Frontiers in Bioscience · doi:10.2741/1472 · Cited by 159
“Although MoMLV did not show a similar strong overall preference for genes, in this case the 5' ends of genes were preferentially targeted over downstream regions (96).”
BackgroundA multi-landing pad DNA integration platform for mammalian cell engineering
Gaidukov, L., Wroblewska, L., Teague, B., Nelson, T., Zhang, X., Liu, Y., Jagtap, K., Mamo, S., Tseng, W. A., Lowe, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky216 · Cited by 160
Gammaretroviral Vectors: Biology, Technology and Application
Maetzig, T., Galla, M., Baum, C., & Schambach, A. (2011) · Viruses · doi:10.3390/v3060677 · Cited by 184
“However, due to the semi-random insertion profile of retroviral vectors, selective intergenic insertions may be difficult to obtain: Gammaretroviruses cluster in the proximity of the transcriptional start site, CpG islands and DNaseI hypersensitive sites, lentiviruses integrate within the whole transcription unit, and…”
BackgroundWu, X., Li, Y., Crise, B., Burgess, S. M., & Munroe, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5211-5214.2005 · Cited by 155
“Recently, there have been several large-scale surveys of retroviral integration sites in the human genome (12, 15, 22, 26).”
BackgroundSelf-citationHanawa, H., Hematti, P., Keyvanfar, K., Metzger, M. E., Krouse, A., Donahue, R. E., Kepes, S., Gray, J., Dunbar, C. E., Persons, D. A., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0045 · Cited by 159
Genome-Wide Analyses of Avian Sarcoma Virus Integration Sites
Narezkina, A., Taganov, K. D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A. M., & Katz, R. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11656-11663.2004 · Cited by 161
“(43), who also used RefSeq genes to map MLV (and HIV-1) integration sites in HeLa cells.”
BackgroundMethodResultInfluentialLarge-scale enhancer detection in the zebrafish genome
Ellingsen, S., Laplante, M. A., König, M., Kikuta, H., Furmanek, T., Hoivik, E. A., & Becker, T. S. (2005) · Development · doi:10.1242/dev.01951 · Cited by 158
“…activated integrated vectors Eight YFP-positive embryos from each enhancer detection line were raised until 5 dpf. Genomic DNA was isolated from each individual larva and flanking genomic sequence of the activated viral integration was amplified using linker mediated PCR (LM-PCR) (Wu et al., 2003).”
BackgroundMethodInfluentialShapiro, J. A. (2005) · Gene · doi:10.1016/j.gene.2004.11.020 · Cited by 166
“…2002; Bowen et al., 2003; Kordis, this issue Murine Leukemia Virus (MLV) Preference for insertion upstream of transcription start sites in human genome Wu et al., 2003; Mitchell et al., 2004 HIV Preference for insertion into actively transcribed regions of human genome Mitchell et al., 2004…”
BackgroundSuccessful treatment of canine leukocyte adhesion deficiency by foamy virus vectors
Bauer, T. R., Allen, J. M., Hai, M., Tuschong, L. M., Khan, I., Olson, E. M., Adler, R. L., Burkholder, T. H., Gu, Y.-C., Russell, D. W., et al. (2007) · Nature Medicine · doi:10.1038/nm1695 · Cited by 155
“We performed linker-mediated (LM)-PCR and LAM-PCR as previously describe”
MethodHarnessing transposons for cancer gene discovery
Copeland, N. G., & Jenkins, N. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2916 · Cited by 164
“First, retroviruses preferentially target the 5′ end of expressed gene”
BackgroundAnson, D. S. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-9 · Cited by 154
HIV integration site distributions in resting and activated CD4 + T cells infected in culture
Brady, T., Agosto, L. M., Malani, N., Berry, C. C., O'Doherty, U., & Bushman, F. (2009) · AIDS · doi:10.1097/qad.0b013e32832caf28 · Cited by 145
“4a, integration was favored within transcription units called by the uniGene and RefSeq databases, as seen in all previous studies of lentiviral integration site distributions [18,21,22,29,31, 36–42].”
Site-directed transposon integration in human cells
Yant, S. R., Huang, Y., Akache, B., & Kay, M. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm089 · Cited by 150
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“Recent analysis of the consensus HIV-1 integration site (-3)TDG↓(G/V)TWA(C/B)CHA(7) highlighted the dinucleotide signature (0)RYXRY(4) at its center.”
BackgroundGene Therapy--New Challenges Ahead
Williams, D. A., & Baum, C. (2003) · Science · doi:10.1126/science.1091258 · Cited by 149
Smith, S. N., Hwang, J., Banerjee, S., Majeed, A., Gupta, A., & Myung, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403093101 · Cited by 165
HIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery
Albanese, A., Arosio, D., Terreni, M., & Cereseto, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002413 · Cited by 138
Wang, G. P., Levine, B. L., Binder, G. K., Berry, C. C., Malani, N., McGarrity, G., Tebas, P., June, C. H., & Bushman, F. D. (2009) · Molecular Therapy · doi:10.1038/mt.2009.16 · Cited by 143
Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
Ferris, A. L., Wu, X., Hughes, C. M., Stewart, C., Smith, S. J., Milne, T. A., Wang, G. G., Shun, M.-C., Allis, C. D., Engelman, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914142107 · Cited by 141
“Linker-mediated PCR (LM-PCR) was used to amplify the junctions of integration sites and genomic DNA, as described previously (4, 29).”
MethodSelf-citationCurrent Advances in Retroviral Gene Therapy
Yi, Y., Jong Noh, M., & Hee Lee, K. (2011) · Current Gene Therapy · doi:10.2174/156652311795684740 · Cited by 143
“Retroviral integration is not a completely random process but favors promoters and enhancer regions while lentiviral vectors integrate more randomly throughout the entire gene [50, 51].”
BackgroundBell, J. B., Podetz-Pedersen, K. M., Aronovich, E. L., Belur, L. R., McIvor, R. S., & Hackett, P. B. (2007) · Nature Protocols · doi:10.1038/nprot.2007.471 · Cited by 145
Integrase, LEDGF/p75 and HIV replication
Poeschla, E. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7540-5 · Cited by 165
Retroviral DNA Integration—Mechanism and Consequences
Lewinski, M. K., & Bushman, F. D. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)55005-3 · Cited by 257
“, 1990), all retroviruses tested exhibit nonrandom selection of integration target sites in cells (Mitchell et al., 2004; Schroder et al., 2002; Wu et al., 2003).”
BackgroundPotential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Tosi, G., Bortot, B., Ruozi, B., Dolcetta, D., Vandelli, M. A., Forni, F., & Severini, G. M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320170006 · Cited by 136
“Furthermore, both cretroviral and lentiviral vectors exhibit preferential integration into expressed genes [158-161], which increase the risk of insertional oncogenesis and tumor development.”
BackgroundThe Suicide Gene Therapy Challenge: How to Improve a Successful Gene Therapy Approach
Bonini, C., Bondanza, A., Perna, S. K., Kaneko, S., Traversari, C., Ciceri, F., & Bordignon, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300190 · Cited by 140
Sleeping Beauty Transposon‐Mediated Gene Therapy for Prolonged Expression
Hackett, P. B., Ekker, S. C., Largaespada, D. A., & McIvor, R. S. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54009-4 · Cited by 145
Gupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
“To clone FLAG-tagged deletion constructs for MLV IN, IN fragments were PCR amplified from pQMLV-IN-FLAG plasmid using the following primer pairs: IN(110-409) ( NTD), SG1 and PC595; IN(160-409) ( CCD), SG2 and PC595; IN(1-278) ( CTD), PC594 and SG3; IN(160359) ( CCD CTD), SG2 and SG4.”
BackgroundMethodOhlfest, J. R., Frandsen, J. L., Fritz, S., Lobitz, P. D., Perkinson, S. G., Clark, K. J., Nelsestuen, G., Key, N. S., McIvor, R. S., Hackett, P. B., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3496 · Cited by 136
Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors
Bokhoven, M., Stephen, S. L., Knight, S., Gevers, E. F., Robinson, I. C., Takeuchi, Y., & Collins, M. K. (2009) · Journal of Virology · doi:10.1128/jvi.01865-08 · Cited by 138
“G18 2 N Il3 16187 11 2,607 bp downstream Cytokine/growth factor activity N Fbxo9 71538 9 3,183 bp upstream Ubiquitin-protein ligase activity N Ick 56542 5,744 bp upstream Protein kinase activity, signal transduction Control CNCG 2 1 Y Tpm3 59069 3 8,408 bp, intron 2-3 Regulation of muscle contraction 1 CNCG 6 1 N Mll2…”
BackgroundMethodInfluentialRetroviral integration and human gene therapy
Bushman, F. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32949 · Cited by 138
Schrijvers, R., De Rijck, J., Demeulemeester, J., Adachi, N., Vets, S., Ronen, K., Christ, F., Bushman, F. D., Debyser, Z., & Gijsbers, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002558 · Cited by 134
“The consensus sequence for the different cell lines was similar to that determined previously [28–30].”
ResultYao, S., Sukonnik, T., Kean, T., Bharadwaj, R. R., Pasceri, P., & Ellis, J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.04.007 · Cited by 133
“Retrovirus and lentivirus preferentially integrate near to or within genes, but approximately 30% of the integration sites are distant from genes [27,28].”
BackgroundGenome editing at the crossroads of delivery, specificity, and fidelity
Maggio, I., & Gonçalves, M. A. F. V. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.02.011 · Cited by 132
Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches
Bocchi, R., Masserdotti, G., & Götz, M. (2022) · Neuron · doi:10.1016/j.neuron.2021.11.023 · Cited by 130
Novel Integrase-Defective Lentiviral Episomal Vectors for Gene Transfer
Vargas, J., Gusella, G. L., Najfeld, V., Klotman, M. E., & Cara, A. (2004) · Human Gene Therapy · doi:10.1089/104303404322959515 · Cited by 133
“In fact, detailed studies of integration sites associated with HIV-based lentiviral vectors have shown that transcriptionally active chromosomal regions are favored as integration targets (Schroder et al., 2002; Wu et al., 2003).”
RNA viruses and the host microRNA machinery
tenOever, B. R. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2971 · Cited by 141
Estimating abundances of retroviral insertion sites from DNA fragment length data
Berry, C. C., Gillet, N. A., Melamed, A., Gormley, N., Bangham, C. R. M., & Bushman, F. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts004 · Cited by 130
“…et al. , 2008) and sequencing the fragments (Hacein-Bey-Abina et al. , 2003; Mitchell et al. , 2004; Schroder et al. , 2002; Wang et al. , 2007; Wu et al. , 2003) potentially allows characterization of the relative abundance of cell clones marked by distinct integration sites (Gabriel et al. ,…”
Genome-wide Mapping of PiggyBac Transposon Integrations in Primary Human T Cells
Galvan, D. L., Nakazawa, Y., Kaja, A., Kettlun, C., Cooper, L. J. N., Rooney, C. M., & Wilson, M. H. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b2914c · Cited by 131
“Gammaretroviral vectors integrate into RefSeq genes at a frequency of 47% to 54% with a preference for TSS and CpG areas.(7,23) Lentiviral integration into active genes has been reported to occur at a frequency of 72% to 82%.”
BackgroundCarlson, C. M., Frandsen, J. L., Kirchhof, N., McIvor, R. S., & Largaespada, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502974102 · Cited by 133
RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain
Son, S., Hwang, D. W., Singha, K., Jeong, J. H., Park, T. G., Lee, D. S., & Kim, W. J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.011 · Cited by 141
Mechanisms of Retroviral Integration and Mutagenesis
Cavazza, A., Moiani, A., & Mavilio, F. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.203 · Cited by 125
“, 2002) or gene promoters in the case of the Moloney murine leukemia virus (MLV) (Wu et al., 2003).”
InfluentialMYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors
Peter, M., Rosty, C., Couturier, J., Radvanyi, F., Teshima, H., & Sastre-Garau, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209625 · Cited by 114
“Extensive analyses of retrovirus integration sites have shown that active genes (Schroder et al., 2002) or transcription start regions (Wu et al., 2003) are preferential integration targets.”
BackgroundFunctional and structural characterization of the integrase from the prototype foamy virus
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn938 · Cited by 130
Ikeda, T., Shibata, J., Yoshimura, K., Koito, A., & Matsushita, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/510915 · Cited by 124
Arumugam, P. I., Scholes, J., Perelman, N., Xia, P., Yee, J.-K., & Malik, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300259 · Cited by 124
Integrase-defective lentiviral vectors: Progress and applications
Banasik, M. B., & McCray, P. B. (2010) · Gene Therapy · doi:10.1038/gt.2009.135 · Cited by 129
Retroviral DNA integration: HIV and the role of LEDGF/p75
Ciuffi, A., & Bushman, F. D. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.05.006 · Cited by 152
“HIV can infect dividing and non-dividing cells, whereas MLV PICs require cell division to enter the nucleus and integrate [ 33 ,43].”
BackgroundResultInfluentialXue, X., Huang, X., Nodland, S. E., Mátés, L., Ma, L., Izsvák, Z., Ivics, Z., LeBien, T. W., McIvor, R. S., Wagner, J. E., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210005 · Cited by 126
High-throughput insertional mutagenesis screens in mice to identify oncogenic networks
Kool, J., & Berns, A. J. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2647 · Cited by 137
“For example, MuLV favours integration near the 5′ end of genes, whereas HIV prefers integration into active gene”
BackgroundINSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes
Sherman, E., Nobles, C., Berry, C. C., Six, E., Wu, Y., Dryga, A., Malani, N., Male, F., Reddy, S., Bailey, A., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.002 · Cited by 124
“14 15 , 34 51 We fi rst describe optimized biochemical methods for integration site isolation, which achieve the critical criteria of suppressing PCR contamination between samples while sampling randomly from the pool of integrated DNAs.”
MethodZhang, T., Barber, A., & Sentman, C. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0130 · Cited by 122
“for extracellular domain of MICA (1-308) was amplified with a histine tag”
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging
Swartling, F. J., Brodd, J., Eklöf, C., Ferletta, M., Hesselager, G., Tiger, C., Uhrbom, L., & Westermark, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402716101 · Cited by 128
Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors
Schambach, A., Galla, M., Maetzig, T., Loew, R., & Baum, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300152 · Cited by 127
Retroviral vectors: new applications for an old tool
Barquinero, J., Eixarch, H., & Pérez-Melgosa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302363 · Cited by 129
Leung, D. C., Dong, K. B., Maksakova, I. A., Goyal, P., Appanah, R., Lee, S., Tachibana, M., Shinkai, Y., Lehnertz, B., Mager, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014660108 · Cited by 125
“Despite the fact that MLV preferentially integrates within or near the promoter regions of genes (44), DNA methylation and transcriptional silencing of such vectors are frequently observed (1), explaining in part why they have shown limited efficacy.”
BackgroundRetroviral Gene Therapy: Safety Issues and Possible Solutions
Yi, Y., Hahm, S. H., & Lee, K. (2005) · Current Gene Therapy · doi:10.2174/1566523052997514 · Cited by 145
Wang, G. P., Berry, C. C., Malani, N., Leboulch, P., Fischer, A., Hacein-Bey-Abina, S., Cavazzana-Calvo, M., & Bushman, F. D. (2010) · Blood · doi:10.1182/blood-2009-12-257352 · Cited by 123
Imren, S., Fabry, M. E., Westerman, K. A., Pawliuk, R., Tang, P., Rosten, P. M., Nagel, R. L., Leboulch, P., Eaves, C. J., & Humphries, R. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421838 · Cited by 126
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Measles and rubella elimination in the WHO Region for Europe: progress and challenges
O'Connor, P., Jankovic, D., Muscat, M., Ben-Mamou, M., Reef, S., Papania, M., Singh, S., Kaloumenos, T., Butler, R., & Datta, S. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.003 · Cited by 107
Integration target site selection by a resurrected human endogenous retrovirus
Brady, T., Lee, Y. N., Ronen, K., Malani, N., Berry, C. C., Bieniasz, P. D., & Bushman, F. D. (2009) · Genes & Development · doi:10.1101/gad.1762309 · Cited by 120
“MLV strongly favored integration near CpG islands (>15-fold) and DNase sites ( Wu et al. 2003; Berry et al. 2006; Lewinski et al. 2006).”
BackgroundInfluentialKoh, Y., Wu, X., Ferris, A. L., Matreyek, K. A., Smith, S. J., Lee, K., KewalRamani, V. N., Hughes, S. H., & Engelman, A. (2013) · Journal of Virology · doi:10.1128/jvi.01148-12 · Cited by 122
“In contrast to the lentiviruses, MLV preferentially integrates into promoter regions and affiliated CpG islands rather than the internal regions of genes (13).”
ResultSelf-citationStachowiak, A. N., & Irvine, D. J. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31661 · Cited by 122
Beard, B. C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D. G., Jacobs, M. A., Kaul, R., Kiem, H.-P., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300159 · Cited by 118
Active retrotransposition by a synthetic L1 element in mice
An, W., Han, J. S., Wheelan, S. J., Davis, E. S., Coombes, C. E., Ye, P., Triplett, C., & Boeke, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605300103 · Cited by 116
Large-scale gene trapping in C57BL/6N mouse embryonic stem cells
Hansen, G. M., Markesich, D. C., Burnett, M. B., Zhu, Q., Dionne, K. M., Richter, L. J., Finnell, R. H., Sands, A. T., Zambrowicz, B. P., & Abuin, A. (2008) · Genome Research · doi:10.1101/gr.078352.108 · Cited by 121
“When no selection scheme is used, murine leukemia retroviruses (MLV) exhibit a nondirectional preference for inserting near the TSSs of genes (Wu et al. 2003).”
BackgroundInfluentialTranslating Sleeping Beauty transposition into cellular therapies: Victories and challenges
Izsvák, Z., Hackett, P. B., Cooper, L. J. N., & Ivics, Z. (2010) · BioEssays · doi:10.1002/bies.201000027 · Cited by 130
Meekings, K. N., Leipzig, J., Bushman, F. D., Taylor, G. P., & Bangham, C. R. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000027 · Cited by 114
“This finding is consistent with previous evidence that the distribution of retroviral integration sites is largely independent of the cell type [1,4,6,22,36–39].”
BackgroundResultA large-scale zebrafish gene knockout resource for the genome-wide study of gene function
Varshney, G. K., Lu, J., Gildea, D. E., Huang, H., Pei, W., Yang, Z., Huang, S. C., Schoenfeld, D., Pho, N. H., Casero, D., et al. (2013) · Genome Research · doi:10.1101/gr.151464.112 · Cited by 115
“This is consistent with the previous studies in mice (Mooslehner et al. 1990; Scherdin et al. 1990) and human tissue culture cells (Wu et al. 2003).”
ResultSelf-citationHIV latency and integration site placement in five cell-based models
Sherrill-Mix, S., Lewinski, M. K., Famiglietti, M., Bosque, A., Malani, N., Ocwieja, K. E., Berry, C. C., Looney, D., Shan, L., Agosto, L. M., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-90 · Cited by 110
“[52] and Mitchell et al.”
Epigenetic Regulation of Lentiviral Transgene Vectors in a Large Animal Model
Hofmann, A., Keßler, B., Sonja, E., Kabermann, A., Brem, G., Wolf, E., & Pfeifer, A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.685 · Cited by 131
“While 17% of MuLV integration sites are found within 1 kb of CpG islands, only 2% of HIV integrations land in the vicinity of CpG islands [32].”
BackgroundInsertional mutagenesis in gene therapy and stem cell biology
Baum, C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3281900f01 · Cited by 108
Hanawa, H., Hargrove, P. W., Kepes, S., Srivastava, D. K., Nienhuis, A. W., & Persons, D. A. (2004) · Blood · doi:10.1182/blood-2004-03-0863 · Cited by 115
Metadata
- Authors
- Wu, X., Li, Y., Crise, B., & Burgess, S. M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Burgess, Shawn M.
- Venue
- Science
- Published
- 2003-06-13
- Volume
- 300
- Issue
- 5626
- Pages
- 1749-1751
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1637867377
- Cited by
- 1,305
- References
- 18
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 25 · 2020: 27 · 2019: 33 · 2018: 24 · 2017: 39 · 2016: 43 · 2015: 49 · 2014: 65 · 2013: 51 · 2012: 83
- FWCI
- 57.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Keywords
- retroviral integration, transcription start sites, murine leukemia virus, HIV-1, human genome, gene therapy
- MeSH terms
- Child, Genetic Vectors, HeLa Cells, Humans, Leukemia, Leukemia Virus, Murine, Promoter Regions, Genetic, Transcription, Genetic, Tumor Cells, Cultured, Genetic Therapy, HIV-1, Gene Expression, Genome, Human, Virus Integration, CpG Islands, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.